Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Leiden
- Most recent report
- 6-K, filed Sep 8, 2026
- Filings on record
- 294 filings
- On EDGAR
- CIK 1830487
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 79
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 12, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 26, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 11, 2026
- 6-K Report a foreign issuer made public elsewhere May 12, 2026
- 6-K Report a foreign issuer made public elsewhere May 11, 2026
- 20-F Annual report, foreign issuer Apr 2, 2026
Prospectuses and Registrations 8 of 13
- 424B5 Prospectus supplement for an offering May 8, 2026
- 424B5 Prospectus supplement for an offering Jul 24, 2025
- FWP Free writing prospectus Jul 23, 2025
- 424B5 Prospectus supplement for an offering Jul 22, 2025
- 424B5 Prospectus supplement for an offering Dec 7, 2023
- FWP Free writing prospectus Dec 6, 2023
- 424B5 Prospectus supplement for an offering Aug 24, 2023
- F-3 Aug 7, 2023
Ownership 8 of 166
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 4 Insider reported a trade Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 8, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 144 Notice of a proposed sale of restricted stock Aug 14, 2026
- 4 Insider reported a trade Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
Other 8 of 36
Everything here comes from Pharvaris N.V.'s own filings on SEC EDGAR. The filing list is rechecked every hour.